 |
 |
|
| Startseite |
| Impressum |
| Datenschutz |
 | ||
| Volume 36, 15 April 2005 | 4/2005 | |
| NEW ON THE MARKET | |
Atomoxetine (STRATTERA) in attention deficit hyperactivity disorder (ADHD) | |
| REVIEW | |
Biologicals efalizumab (RAPTIVA) and etanercept (ENBREL) in psoriasis | |
| THERAPIES FROM A CRITICAL VIEWPOINT | |
TNT-study with atorvastatine (SORTIS): more is not better | |
 |
Clopidogrel (ISCOVER, PLAVIX) in acute myocardial infarction? |
| BEWARE MISINFORMATION | |
Withdrawal from the market of the cox-2 inhibitor valdecoxib (BEXTRA) | |
| IN BRIEF | |
Value of proton pump inhibitors in bleeding peptic ulcer | |
| CURRENT ADR NETWORK REPORT | |
Tinnitus with proton pump inhibitors - a group effect | |
|
© arznei-telegramm 4/2005 | ||
 |  | |